ST. Jude Medical PressureWire FFR Catherter
Feature

St. Jude Medical Inc., a global medical device company, announced that fractional flow reserve (FFR)-guided treatment using PressureWire was cost effective for coronary interventions when compared to the best available medical therapy. Cost utility analysis data from the FAME II trial was presented as a late-breaking clinical trial at the 24th annual Transcatheter Cardiovascular Therapeutics (TCT) scientific symposium, sponsored by the Cardiovascular Research Foundation.

Home October 30, 2012
Home
DESolve Nx Pivotal Trial Bioresorbable Coronary Stent Elixir Cath Lab
Feature

Elixir Medical Corp. announced enrollment completion of the 120-patient, pivotal clinical trial evaluating the safety and efficacy of the DESolve Novolimus-Eluting Bioresorbable Coronary Scaffold System. The scaffold is designed to resorb in the body within one to two years after implantation and return the patients’ coronary vessel to de novo state.

Home October 30, 2012
Home
Technology

The Philips IntelliSpace Portal is an advanced visualization solution designed to simplify the way radiologists work, think and care for patients by delivering on the promise of real-time radiology.

Home October 29, 2012
Home
Technology

October 29, 2012 — At RSNA 2012, GE Healthcare will unveil innovations in healthcare IT, including enhancements to Centricity PACS (picture archiving and communication system) and PACS-IW. The PACS-IW system aligns advanced visualization, breast imaging and intelligent tools with a unified desktop.

Home October 29, 2012
Home
News

Boston Scientific Corporation has received regulatory approval to market the Reliance 4-Front lead, its next generation implantable defibrillation lead now available in Europe and Asia. Defibrillation leads are insulated wires that connect an implantable cardioverter defibrillator (ICD) or cardiac resynchronization therapy defibrillator to the heart for treatment of heart failure and sudden cardiac arrest.

Home October 29, 2012
Home
Technology

October 29, 2012 — Brainlab released Buzz Digital OR, a major step forward in information integration for the surgical suite. Buzz encompasses a vast spectrum, from pure DICOM viewing to complete digital operating room (OR) functionality, including video management and documentation.

Home October 29, 2012
Home
Technology

Covidien announced final 12-month results from its DEFINITIVE LE (Determination of Effectiveness of SilverHawk/TurboHawk Peripheral Plaque Excision Systems for the Treatment of Infrainguinal Vessels/Lower Extremities) study.

Home October 26, 2012
Home
News

Biotronik began its European market release of BioMonitor, an implantable cardiac device designed for accurate and reliable monitoring and management of patients with atrial fibrillation (AF) or unexplained syncope.

Home October 26, 2012
Home
News

October 25, 2012 — Lantheus Medical Imaging Inc. announced it has extended its contract with Nordion to supply molybdenum-99 (Mo-99) for use in its TechneLite (Technetium Tc-99m) generators.

Home October 25, 2012
Home
Technology

October 25, 2012 — InterSystems Corp., a provider of software for healthcare interoperability, and eHealth Technologies, a provider of imaging solutions for electronic health records (EHR) and health information exchange (HIE) solutions, entered a partnership to provide single-click access to diagnostic-quality images via the InterSystems HealthShare strategic informatics platform.

Home October 25, 2012
Home
News

Avinger Inc., a medical device manufacturer of multi-functional catheters for crossing CTOs in patients with peripheral artery disease (PAD), announced its CONNECT II global clinical trial results at the Vascular Interventional Advances (VIVA) Conference 2012 in Las Vegas, Nev.

Home October 24, 2012
Home
News

An online poll of physicians who lead hospitals, health systems and large group practices across the United States conducted after the first presidential debate found more preferred Republican challenger Mitt Romney's plan to reform Medicare than President Barack Obama's, with many still undecided.

Home October 24, 2012
Home
News

October 23, 2012 — A study found that a tailored therapy approach that adjusts the loading dose of clopidogrel according to measured platelet reactivity is superior to prasugrel therapy in reducing high platelet reactivity (a risk factor for worse outcomes) in patients with acute coronary syndrome (ACS). Results of the trial were presented at the 24th annual Transcatheter Cardiovascular Therapeutics (TCT) scientific symposium.

Home October 23, 2012
Home
News

October 23, 2012 — In the DEBATE-SFA trial, researchers found that the use of a paclitaxel drug-eluting balloon (DEB) to widen the artery prior to implanting a self-expanding nitinol stent yielded a lower restenosis rate after one year. Results of the trial were presented at the 24th annual Transcatheter Cardiovascular Therapeutics (TCT) scientific symposium.

Home October 23, 2012
Home
News

October 22, 2012 — W. L. Gore & Associates announced that the U.S. Food and Drug Administration (FDA) has approved the use of the new Gore septal occluder for inclusion in the Gore REDUCE clinical study.

Home October 22, 2012
Home
Subscribe Now